HHLA2 and ovarian carcinoma: Guocai Xu et al. reported that HHLA2 expression is an independent prognostic factor that predicted improved survival in ovarian cancer; moreover, they found that overexpressing HHLA2 inhibited the proliferation of ovarian cancer cells [20].